China IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: June 23, 2025 Report Code: GDME25587CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “China IVD Analyzers Market Outlook to 2033” is a comprehensive databook report, covering key market data on the China IVD Analyzers market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers, Clinical Chemistry Analyzers, Integrated Clinical Chemistry & Immunochemistry Analyzers, Immunochemistry Analyzers and Next Generation Sequencers

The China IVD Analyzers Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for IVD Analyzers Market.
• Global corporate-level profiles of key companies operating within the China IVD Analyzers Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China IVD Analyzers is segmented as follows – _x000D_

• Hematology Analyzers_x000D_

• Polymerase Chain Reaction (PCR) Systems_x000D_

• Point of Care (POC) Analyzers_x000D_

• Clinical Chemistry Analyzers_x000D_

• Integrated Clinical Chemistry & Immunochemistry Analyzers_x000D_

• Immunochemistry Analyzers_x000D_

• Next Generation Sequencers

Reasons to Buy

The China IVD Analyzers Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Abaxis Inc

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 IVD Analyzers Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 IVD Analyzers Market, China 11

3.1 IVD Analyzers Market, China, Revenue ($m), 2018-2033 11

3.1.1 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2018-2033 13

3.1.2 Hematology Analyzers Market, China, Revenue ($m), by Segment, 2018-2033 15

3.1.3 Immunochemistry Analyzers Market, China, Revenue ($m), by Segment, 2018-2033 17

3.1.4 Next Generation Sequencers Market, China, Revenue ($m), by Segment, 2018-2033 19

3.1.5 Point of Care (POC) Analyzers Market, China, Revenue ($m), by Segment, 2018-2033 21

3.1.6 Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), by Segment, 2018-2033 23

3.2 IVD Analyzers Market, China, Volume (Units), 2018-2033 25

3.2.1 Clinical Chemistry Analyzers Market, China, Volume (Units), by Segment, 2018-2033 27

3.2.2 Hematology Analyzers Market, China, Volume (Units), by Segment, 2018-2033 29

3.2.3 Immunochemistry Analyzers Market, China, Volume (Units), by Segment, 2018-2033 31

3.2.4 Next Generation Sequencers Market, China, Volume (Units), by Segment, 2018-2033 33

3.2.5 Point of Care (POC) Analyzers Market, China, Volume (Units), by Segment, 2018-2033 35

3.2.6 Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), by Segment, 2018-2033 37

3.3 IVD Analyzers Market, China, Average Price ($) , 2018-2033 39

3.4 IVD Analyzers Market, China, Company Share by Revenue ($m), 2024 44

4 Overview of Key Companies in China, IVD Analyzers Market 46

4.1 F. Hoffmann-La Roche Ltd 46

4.1.1 Company Overview 46

4.2 Danaher Corp 46

4.2.1 Company Overview 46

4.3 Abbott Laboratories 46

4.3.1 Company Overview 46

4.4 Siemens Healthineers AG 46

4.4.1 Company Overview 46

4.5 Sysmex Corp 47

4.5.1 Company Overview 47

4.6 Bio-Rad Laboratories Inc 47

4.6.1 Company Overview 47

4.7 Thermo Fisher Scientific Inc 47

4.7.1 Company Overview 47

4.8 bioMerieux SA 47

4.8.1 Company Overview 47

4.9 Qiagen NV 48

4.9.1 Company Overview 48

4.10 Hologic Inc 48

4.10.1 Company Overview 48

5 IVD Analyzers Market Pipeline Products 49

6 Financial Deals Landscape 62

6.1 Equity Offerings 62

6.1.1 IVD Medical to Raise Upto USD24.22 Million in Private Placement of Shares 62

6.2 Venture Financing 64

6.2.1 Beijing Liang Biotechnology (Liangping Bio, Hunan Liangping Biotechnology) Raises Funds through Angel Financing 64

7 Recent Developments 65

7.1 Corporate Communications 65

7.1.1 Nov 21, 2024: United Imaging Announces the First of Several New U.S. Product Launches For RSNA 65

7.1.2 Sep 10, 2024: Qlife is to Announce that Peter Warthoe will Return to the Management Group as Chief Scientific Officer 66

7.2 Legal And Regulatory 66

7.2.1 Oct 08, 2024: Microport Medbot Skywalker Orthopedic Surgical Robot Gets Approval in Japan 66

7.3 Other Significant Developments 67

7.3.1 Jan 07, 2025: Qlife Provides Update on Operational Progress in China 67

7.3.2 Sep 04, 2024: Production Of Egoo Consumables Now Established In China To Support On-going Clinical Trials And Future Sales 67

8 Appendix 69

8.1 Research Methodology 70

8.1.1 Coverage 70

8.1.2 Secondary Research 70

8.1.3 Primary Research 70

8.1.4 Market Modeling and Forecasting 71

8.1.5 Company Share Analysis 72

8.1.6 Benchmarking 73

8.2 GlobalData Consulting 74

8.3 Contact Us 74

8.4 Disclaimer 74

Table

Table 1: IVD Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 12

Table 2: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 14

Table 3: Hematology Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 16

Table 4: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 18

Table 5: Next Generation Sequencers Market, China, Revenue ($m), USD Constant, 2018-2033 20

Table 6: Point of Care (POC) Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 22

Table 7: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, 2018-2033 24

Table 8: IVD Analyzers Market, China, Volume (Units), 2018-2033 26

Table 9: Clinical Chemistry Analyzers Market, China, Volume (Units), 2018-2033 28

Table 10: Hematology Analyzers Market, China, Volume (Units), 2018-2033 30

Table 11: Immunochemistry Analyzers Market, China, Volume (Units), 2018-2033 32

Table 12: Next Generation Sequencers Market, China, Volume (Units), 2018-2033 34

Table 13: Point of Care (POC) Analyzers Market, China, Volume (Units), 2018-2033 36

Table 14: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), 2018-2033 38

Table 15: IVD Analyzers Market, China, Average Price ($), 2018-2033 39

Table 16: IVD Analyzers Market, China, Company Share by Revenue ($m), 2024 45

Table 17: IVD Analyzers Market Pipeline Products 49

Table 18: IVD Medical to Raise Upto USD24.22 Million in Private Placement of Shares 62

Table 19: Beijing Liang Biotechnology (Liangping Bio, Hunan Liangping Biotechnology) Raises Funds through Angel Financing 64

Table 20: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 71

Figures

Figure 1: IVD Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 13

Figure 3: Hematology Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 15

Figure 4: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 17

Figure 5: Next Generation Sequencers Market, China, Revenue ($m), USD Constant, 2018-2033 19

Figure 6: Point of Care (POC) Analyzers Market, China, Revenue ($m), USD Constant, 2018-2033 21

Figure 7: Polymerase Chain Reaction (PCR) Systems Market, China, Revenue ($m), USD Constant, 2018-2033 23

Figure 8: IVD Analyzers Market, China, Volume (Units), 2018-2033 25

Figure 9: Clinical Chemistry Analyzers Market, China, Volume (Units), 2018-2033 27

Figure 10: Hematology Analyzers Market, China, Volume (Units), 2018-2033 29

Figure 11: Immunochemistry Analyzers Market, China, Volume (Units), 2018-2033 31

Figure 12: Next Generation Sequencers Market, China, Volume (Units), 2018-2033 33

Figure 13: Point of Care (POC) Analyzers Market, China, Volume (Units), 2018-2033 35

Figure 14: Polymerase Chain Reaction (PCR) Systems Market, China, Volume (Units), 2018-2033 37

Figure 15: IVD Analyzers Market, China, Company Share (%), 2024 44

China IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports

Medical Devices

New

Global M&A Deals in H1 2026 - Top Themes by…

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at China IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others in real time.

Access a live China IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

China IVD Analyzers Market Outlook to 2033: Hematology Analyzers, Polymerase Chain Reaction (PCR) Systems, Point of Care (POC) Analyzers and Others

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports